Ailanthone & CRPC
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.
He Y1, Peng S1, Wang J1, Chen H1, Cong X1, Chen A1, Hu M1, Qin M1, Wu H1, Gao S1, Wang L2, Wang X1, Yi Z1, Liu M1,3.
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.
He Y1, Peng S1, Wang J1, Chen H1, Cong X1, Chen A1, Hu M1, Qin M1, Wu H1, Gao S1, Wang L2, Wang X1, Yi Z1, Liu M1,3.